Breaking News
Andrew Hopkins
About Andrew Hopkins
Andrew Lee Hopkins FRSE FRSC FRSB FLSW is a Welsh technology entrepreneur and biophysicist. He is the founder and Chief Executive Officer of Exscientia, a pharmatech company that uses artificial intelligence (AI) to efficiently discover new drugs. At Exscientia, Hopkins oversaw the discovery of the world’s first novel, precision engineered drug generated and optimized by AI, to enter human clinical trials.
Hopkins’s primary research interest is the science of drug discovery. His innovation in modern drug discovery informatics led to the development of machine learning and artificial intelligence to automate the design of drugs. Hopkins has pioneered several widely applied drug discovery concepts, such as the druggable genome, network pharmacology and ligand efficiency.
Hopkins is an honorary professor at the School of Life Sciences, University of Dundee, where previous he held the Chair of Medicinal Informatics and was the SULSA Research Professor of Translational Biology. He is also the former Director of Scottish Universities Life Sciences Alliance (SULSA).